Skip to main content
PMC home page
Gut logoLink to Gut
. 1995 Oct;37(4):477–481. doi: 10.1136/gut.37.4.477

Omeprazole enhances efficacy of triple therapy in eradicating Helicobacter pylori.

T J Borody 1, P Andrews 1, G Fracchia 1, S Brandl 1, N P Shortis 1, H Bae 1
PMCID: PMC1382896  PMID: 7489931

Abstract

Triple therapy has been recommended as the most effective treatment for Helicobacter pylori eradication. Despite achieving a comparatively high eradication result, however, around 10% of patients still fail to be cured. Omeprazole can enhance efficacy of single and double antibiotic protocols and is particularly effective when combined with clarithromycin and a nitroimidazole. This study examined the effect of combining triple therapy with omeprazole. A prospective, randomised, unblinded, single centre trial was carried out on consecutive patients with symptoms of dyspepsia and H pylori infection confirmed by rapid urease test, microbiological culture, and histological assessment. Patients were given a five times/day, 12 day course of colloidal bismuth subcitrate chewable tablets (108 mg), tetracycline HCl (250 mg), and metronidazole (200 mg) with either 20 mg omeprazole twice daily (triple therapy+omeprazole) or 40 mg famotidine (triple therapy+famotidine) at night. Compliance and side effects were determined using a standard questionnaire form. One hundred and twenty five of 165 triple therapy+omeprazole patients and 124 of 171 triple therapy+famotidine patients returned for rebiopsy four weeks after completion of treatment. Significantly more triple therapy+omeprazole patients achieved eradication 122 of 125 (97.6%) as assessed by negative urease test, culture, and histological assessment, when compared with 110 of 124 (89%) triple therapy+famotidine patients (p = 0.006; chi 2). There were 30 triple therapy+omeprazole (24%) and 26 triple therapy+famotidine (21%) patients with de novo metronidazole resistant H pylori included in the study. Side effects were mild and infrequent and were comparable in both groups, although pain in duodenal ulcer, gastric ulcer, and oesophagitis patients seemed to subside earlier in those taking omeprazole. Compliance (>95% of drugs taken) was achieved by 98% of patients of both groups. A 12 days regimen of triple therapy with omeprazole is more effective in achieving H pylori eradication than is triple therapy plus famotidine. Use of 20 mg omeprazole twice daily rather than 40 mg famotidine with a 12 day, low dose triple therapy enhances eradication to over 97% whether the H pylori is metronidazole sensitive or resistant.

Full text

PDF
477

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Axon A. T. Helicobacter pylori therapy: effect on peptic ulcer disease. J Gastroenterol Hepatol. 1991 Mar-Apr;6(2):131–137. doi: 10.1111/j.1440-1746.1991.tb01452.x. [DOI] [PubMed] [Google Scholar]
  2. Batty G. M., Wilkins W. E., Morris J. S. Ulcerative colitis in a husband and wife. Gut. 1994 Apr;35(4):562–563. doi: 10.1136/gut.35.4.562. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bell G. D., Powell K., Burridge S. M., Harrison G., Weil J., Gant P. W., Jones P. H., Trowell J. E. Does a previous course of tripotassium dicitrato bismuthate affect the subsequent chances of successful Helicobacter pylori eradication? Aliment Pharmacol Ther. 1992 Jun;6(3):327–333. doi: 10.1111/j.1365-2036.1992.tb00054.x. [DOI] [PubMed] [Google Scholar]
  4. Borody T. J., Andrews P., Mancuso N., McCauley D., Jankiewicz E., Ferch N., Shortis N. P., Brandl S. Helicobacter pylori reinfection rate, in patients with cured duodenal ulcer. Am J Gastroenterol. 1994 Apr;89(4):529–532. [PubMed] [Google Scholar]
  5. Borody T. J., Brandl S., Andrews P., Ferch N., Jankiewicz E., Hyland L. Use of high efficacy, lower dose triple therapy to reduce side effects of eradicating Helicobacter pylori. Am J Gastroenterol. 1994 Jan;89(1):33–38. [PubMed] [Google Scholar]
  6. Chiba N., Rao B. V., Rademaker J. W., Hunt R. H. Meta-analysis of the efficacy of antibiotic therapy in eradicating Helicobacter pylori. Am J Gastroenterol. 1992 Dec;87(12):1716–1727. [PubMed] [Google Scholar]
  7. Collins R., Beattie S., Xia H. X., O'Morain C. Short report: high-dose omeprazole and amoxycillin in the treatment of Helicobacter pylori-associated duodenal ulcer. Aliment Pharmacol Ther. 1993 Jun;7(3):313–315. doi: 10.1111/j.1365-2036.1993.tb00102.x. [DOI] [PubMed] [Google Scholar]
  8. Hazell S. L., Borody T. J., Gal A., Lee A. Campylobacter pyloridis gastritis I: Detection of urease as a marker of bacterial colonization and gastritis. Am J Gastroenterol. 1987 Apr;82(4):292–296. [PubMed] [Google Scholar]
  9. Hosking S. W., Ling T. K., Chung S. C., Yung M. Y., Cheng A. F., Sung J. J., Li A. K. Duodenal ulcer healing by eradication of Helicobacter pylori without anti-acid treatment: randomised controlled trial. Lancet. 1994 Feb 26;343(8896):508–510. doi: 10.1016/s0140-6736(94)91460-5. [DOI] [PubMed] [Google Scholar]
  10. Hosking S. W., Ling T. K., Yung M. Y., Cheng A., Chung S. C., Leung J. W., Li A. K. Randomised controlled trial of short term treatment to eradicate Helicobacter pylori in patients with duodenal ulcer. BMJ. 1992 Aug 29;305(6852):502–504. doi: 10.1136/bmj.305.6852.502. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Labenz J., Gyenes E., Rühl G. H., Börsch G. Amoxicillin plus omeprazole versus triple therapy for eradication of Helicobacter pylori in duodenal ulcer disease: a prospective, randomized, and controlled study. Gut. 1993 Sep;34(9):1167–1170. doi: 10.1136/gut.34.9.1167. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Labenz J., Gyenes E., Rühl G. H., Börsch G. Omeprazole plus amoxicillin: efficacy of various treatment regimens to eradicate Helicobacter pylori. Am J Gastroenterol. 1993 Apr;88(4):491–495. [PubMed] [Google Scholar]
  13. Laine L. Helicobacter pylori and non-ulcer dyspepsia. Gastroenterology. 1992 Jul;103(1):340–341. doi: 10.1016/0016-5085(92)91135-q. [DOI] [PubMed] [Google Scholar]
  14. McCarthy C. J., Collins R., Beattie S., Hamilton H., O'Morain C. Short report: treatment of Helicobacter pylori-associated duodenal ulcer with omeprazole plus antibiotics. Aliment Pharmacol Ther. 1993 Aug;7(4):463–466. doi: 10.1111/j.1365-2036.1993.tb00121.x. [DOI] [PubMed] [Google Scholar]
  15. Rogers J., Raimundo A. H., Misiewicz J. J. Cephalic phase of colonic pressure response to food. Gut. 1993 Apr;34(4):537–543. doi: 10.1136/gut.34.4.537. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Rowley H., Connolly A., Brady M. P. Alveolar soft part sarcoma presenting as a pulsating tumour of the arm in a young woman. Ir J Med Sci. 1992 Jan;161(1):12–13. doi: 10.1007/BF02984669. [DOI] [PubMed] [Google Scholar]
  17. Thijs J. C., Van Zwet A. A., Oey H. B. Efficacy and side effects of a triple drug regimen for the eradication of Helicobacter pylori. Scand J Gastroenterol. 1993 Nov;28(11):934–938. doi: 10.3109/00365529309098287. [DOI] [PubMed] [Google Scholar]
  18. Tucci A., Corinaldesi R., Stanghellini V., Paparo G. F., Gasperoni S., Biasco G., Varoli O., Ricci-Maccarini M., Barbara L. One-day therapy for treatment of Helicobacter pylori infection. Dig Dis Sci. 1993 Sep;38(9):1670–1673. doi: 10.1007/BF01303176. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES